Biofabrication, published by IOP Publishing Ltd, stands at the forefront of the interdisciplinary fields of biochemistry, bioengineering, biomaterials, biomedical engineering, biotechnology, and miscellaneous medicine. Since its inception in 2009, this prestigious journal has secured its position within the Q1 category across multiple disciplines as of 2023, reflecting its high impact and significant contribution to advancing research in these domains. With ranks such as #19 in biochemistry and #10 in biomaterials according to Scopus, it showcases groundbreaking studies and innovative methodologies that are crucial for the evolution of biofabrication technologies. Authored by leading researchers and professionals, the journal publishes articles that explore the synthesis, characterization, and application of biomaterials, providing valuable insights for both academic researchers and industry practitioners. The impact factor of the journal, combined with its rigorous peer-review process, guarantees high-quality content that pushes the boundaries of knowledge and technology. Researchers and students engaged in these dynamic fields will find Biofabrication an indispensable resource for staying abreast of critical developments and emerging trends.

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

Biomedical Physics & Engineering Express, published by IOP Publishing Ltd, serves as a dynamic platform for the dissemination of groundbreaking research in the interdisciplinary domains of biomedical physics, engineering, and related fields. With a focus on innovative solutions for healthcare challenges, the journal extends its reach to a global audience, providing valuable insights that influence both academic research and practical applications. Operating under an open-access format, this journal ensures that vital scientific discoveries are readily available to researchers, professionals, and students alike. Ranking within the Q3 and Q4 quartiles across various categories—including Bioengineering and Biomedical Engineering—indicates its emerging influence in the scientific community since its inception in 2015. With an increasing footprint in Scopus rankings and a commitment to advancing knowledge in subfields such as biophysics and health informatics, Biomedical Physics & Engineering Express plays a crucial role in shaping future innovations in healthcare technology and patient care.

CMES-COMPUTER MODELING IN ENGINEERING & SCIENCES is a premier journal published by Tech Science Press, dedicated to advancing knowledge in the fields of computer science applications, modeling and simulation, and software engineering. With an impressive convergence of research from 2000 to 2024, this journal stands out as a vital resource for researchers, professionals, and students alike, fostering innovation and collaboration in computational methodologies. The journal currently holds a Q3 category ranking in multiple disciplines according to the latest metrics, including Scopus, which reflects its growing significance in the academic community. By providing a platform for high-quality research and open discourse, CMES aims to enhance the understanding of complex systems through effective modeling techniques and computational tools. Despite its current classification under open access, the journal remains a cornerstone for those looking to deepen their expertise in cutting-edge computational engineering and science.

The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.

Nature Biomedical Engineering is a premier journal published by NATURE PORTFOLIO, focusing on innovative research at the intersection of engineering and biomedical sciences. With an ISSN of 2157-846X, this journal aims to disseminate groundbreaking studies that advance the field of bioengineering, biotechnology, and medical applications. Since its inception in 2017, it has rapidly earned a reputation for excellence, consistently achieving a Q1 ranking in various categories including Bioengineering and Biomedical Engineering, and receiving acclaim in prestigious Scopus rankings, boasting top positions in the fields of Computer Science Applications and Medicine. The journal operates under a rigorous peer-review process, ensuring that all published articles contribute substantially to the existing body of knowledge. Furthermore, it facilitates a broad accessibility model for researchers and practitioners, bolstering collaboration and innovation within the global scientific community. Nature Biomedical Engineering is not just a publication; it serves as a vital platform for thought leadership in the transformative field of biomedical engineering.

Biomedical Engineering and Computational Biology is a premier journal dedicated to advancing the fields of biomedical engineering and computational biology through rigorous research and innovation. Published by SAGE Publications Ltd, this Open Access journal has been providing a platform for the dissemination of high-quality research since 2009, enabling wider accessibility and collaboration among scientists and practitioners around the globe. With its comprehensive scope that encompasses the intersection of engineering principles and biological systems, the journal plays a critical role in fostering advancements in healthcare technologies and computational methods. Researchers, professionals, and students alike can take advantage of its rich repository of articles that contribute significantly to the understanding and application of complex biological data through computational techniques. The journal’s commitment to excellence is reflected in its high visibility within the scientific community, making it an essential resource for those looking to stay at the forefront of this dynamic field.

Bioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.

IEEE Open Journal of Engineering in Medicine and Biology is a premier Open Access journal published by the esteemed IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC, dedicated to advancing the interdisciplinary fields of biomedical engineering and medicine. Since its inception in 2020, the journal has quickly established itself within the academic community, boasting a notable ranking of #49 out of 303 in the Biomedical Engineering category on Scopus and achieving an impressive 83rd percentile. With an objective of disseminating high-quality research and innovative developments that bridge engineering and medical sciences, the journal is committed to fostering collaboration among researchers, healthcare professionals, and policymakers. Operating with Open Access since 2020 allows for wider accessibility and dissemination of cutting-edge findings, promoting the exchange of knowledge vital for tackling contemporary challenges in health technology. As the journal continues to grow through to 2024, it remains a vital resource for anyone invested in the enhancement of medical technology and the betterment of patient care.

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.